The report analyzes and
presents an overview of "
Regeneron Pharmaceuticals, Inc. - Product Pipeline Review - 2016 "
worldwide.
Global
Markets Directs, Regeneron
Pharmaceuticals, Inc. - Product Pipeline Review - 2016,
provides an overview of the Regeneron Pharmaceuticals, Inc.s
pharmaceutical research and development focus.
The
report provides comprehensive information on the therapeutics under
development by Regeneron Pharmaceuticals, Inc., complete with
analysis by stage of development, drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type. The report
also covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and the
dormant and discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report at
Scope
-
The report provides a snapshot of the pipeline therapeutic landscape
of Regeneron Pharmaceuticals, Inc.
-
The report provides overview of Regeneron Pharmaceuticals, Inc.
including its business description, key facts, and locations and
subsidiaries
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report assesses Regeneron Pharmaceuticals, Inc.s pipeline
therapeutics based on drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type
-
The report features Regeneron Pharmaceuticals, Inc.s out-licensed and
partnered product portfolio and summarizes its dormant and
discontinued projects
Reasons to buy
-
Evaluate Regeneron Pharmaceuticals, Inc.s strategic position with
total access to detailed information on its product pipeline
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Regeneron Pharmaceuticals, Inc.
-
Identify potential new clients or partners in the target demographic
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Regeneron Pharmaceuticals, Inc.s pipeline depth and focus of pipeline
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
Table
of Contents
Table
of Contents 2
List
of Tables 6
List
of Figures 6
Introduction
7
Global
Markets Direct Report Coverage 7
Regeneron
Pharmaceuticals, Inc. Snapshot 8
Regeneron
Pharmaceuticals, Inc. Overview 8
Key
Information 8
Key
Facts 8
Regeneron
Pharmaceuticals, Inc. - Research and Development Overview 9
Key
Therapeutic Areas 9
Regeneron
Pharmaceuticals, Inc. - Pipeline Review 12
Pipeline
Products by Stage of Development 12
Pipeline
Products - Monotherapy 13
Pipeline
Products - Combination Treatment Modalities 14
Pipeline
Products - Partnered Products 15
Partnered
Products/Combination Treatment Modalities 16
Regeneron
Pharmaceuticals, Inc. - Pipeline Products Glance 17
Regeneron
Pharmaceuticals, Inc. - Late Stage Pipeline Products 17
Pre-Registration
Products/Combination Treatment Modalities 17
Phase
III Products/Combination Treatment Modalities 18
Regeneron
Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 19
Phase
II Products/Combination Treatment Modalities 19
Phase
I Products/Combination Treatment Modalities 20
Regeneron
Pharmaceuticals, Inc. - Early Stage Pipeline Products 21
Preclinical
Products/Combination Treatment Modalities 21
Discovery
Products/Combination Treatment Modalities 22
Regeneron
Pharmaceuticals, Inc. - Drug Profiles 23
aflibercept
23
Product
Description 23
Mechanism
of Action 23
R&D
Progress 23
alirocumab
26
Product
Description 26
Mechanism
of Action 26
R&D
Progress 26
sarilumab
30
Product
Description 30
Mechanism
of Action 30
R&D
Progress 30
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment